Clinical Trial Update: Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia [NA]

View source ↗

Summary

A completed double-blind, placebo-controlled trial evaluating adjunctive aripiprazole for symptomatic hyperprolactinemia in premenopausal women with schizophren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperprolactinemia
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Hyperprolactinemia | NA | Status: COMPLETED | Results posted: 2018-05-16